Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostatic Neoplasms × poly ICLC × Clear all

Phase

Status

Completed 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Glioblastoma 2 Smoldering Multiple Myeloma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Melanoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

enzalutamide 28 Prednisone 25 Abiraterone Acetate 24 apalutamide 21 Radiotherapy 21 Magnetic Resonance Spectroscopy 20 Leuprolide 19 Androgen Antagonists 18 Radiosurgery 16 Gonadotropin-Releasing Hormone 15 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14 Docetaxel 14 pembrolizumab 11 darolutamide 11 bicalutamide 11 abiraterone 11 Goserelin 10 Carboplatin 10 Radiotherapy, Intensity-Modulated 9 Radiation 9 gallium 68 PSMA-11 8 Brachytherapy 8 relugolix 7 cabazitaxel 7 Triptorelin Pamoate 7 Specimen Handling 7 Pluvicto 7 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 7 prednylidene 6 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05010200 2026-01-07

PGV-Prostate

Icahn School of Medicine at Mount Sinai

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡